TechPat: U.S. Patent No. 10,157,521 B2: GDC Edition
The Game Developers Conference will be held in San Francisco from March 18-22, 2019. To commemorate the GDC, we will highlight two gaming patents during the conference. U.S. Patent No. 10,157,521 B2...
TechPat: U.S. Patent No. D835,596 S: MWC Edition
Mobile World Congress opens in Barcelona, Spain, on February 25-28, 2019. To commemorate the mobile industry’s largest trade show, this blog will showcase various recently issued U.S. patents...
TechPat: U.S. Patent No. 10,123,538 B2
U.S. Patent No. 10,123,538 B2 (‘538), issued on November 13, 2018, for “Glyphosate Salt Herbicidal Composition.” The inventors are David R. Eaton of Kirkwood, Missouri, Jeffrey A. Graham of...
TechPat: U.S. Patent No. 10,091,202 B2: CES Edition
Source: U.S. Patent No. 10,091,202 B2, Oct. 2, 2018, to Aleksandr Kennberg & Alexander Nicolaou (inventors); Google LLC (applicant/assignee) U.S. Patent No. 10,091,202 B2 (‘202), issued on October 2,...
TechPat: U.S. Patent No. 9,860,622 B2: CES Edition
CES 2019 will open January 8 – 11, 2019, in Las Vegas, Nevada, bringing to the world’s eyes gadgets and technology from startups all over the globe. Wearable tech has always been one of the more...
TechPat: U.S. Patent No. 10,057,241 B2
U.S. Patent No. 10,057,241 (‘241) issued on August 21, 2018, for “Toggle Between Accounts.” It was issued to inventors Anand Subramani and François Alexander Allain, both of San Francisco,...
TechPat: U.S. Patent No. D814,846 S1: Thanksgiving Edition
U.S. Patent No. D814,846 S1 (‘846) issued on April 10, 2018, for “Rotisserie Turkey Deep Fryer.” It was issued to inventors James A. Hedrington of Chippewa Falls, Wisconsin and Michael R. Berge of...
Glyphosate Plaintiff Accepts Reduced Punitive Damages Award
On October 26, 2018, the dying plaintiff in the first-of-its-kind case involving Monsanto Co.’s glyphosate product, ROUNDUP®, has accepted a judge’s punitive damages award reduction prior to the...
CannabIP: DEA Schedules CBD – but with Big Caveat
On September 27, 2018, the Drug Enforcement Agency (DEA) scheduled EPIDIOLEX® as a Schedule V regulated drug under the Controlled Substance Act (CSA). In doing so, the DEA has expressly scheduled a...
Monsanto Motion for New Trial Conditionally Denied and JNOV Denied
As a follow-up to our previous posting on the blockbuster glyphosate trial in which a plaintiff suffering from non-Hodgkin’s Lymphoma was awarded $289 million by a San Francisco jury, the judge, on...
No posts found
Try adjusting your filters